Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T21:15:24.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 04 17 7 has been updated to 06 06 8 on the webpage, indicating a recent change in the data related to Medical and healthcare publications and documentation.
    Difference
    1.0%
    Check dated 2024-06-06T14:26:53.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of relevant medical and healthcare-related publications or documentation. This change may reflect the addition of new study records or updates to existing ones.
    Difference
    0.3%
    Check dated 2024-05-22T21:32:45.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:51:10.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.